logo_web
  • Clinical Trials
    • Management of medication
    • Management of reimbursement of expenses to patients
    • Supply of medical devices
    • Destruction
    • Calibration of medical devices
    • Import and labeling of medication
    • Masking. Placebos manufacturing
  • Blog
  • Quality
    • Certifications
    • RSE
  • Clients
  • Patient Reimbursement Forms
    • Validation / Expense Reimbursement Sheet
✕
  • Clinical Trials
    • Management of medication
    • Management of reimbursement of expenses to patients
    • Supply of medical devices
    • Destruction
    • Calibration of medical devices
    • Import and labeling of medication
    • Masking. Placebos manufacturing
  • Blog
  • Quality
    • Certifications
    • RSE
  • Clients
  • Patient Reimbursement Forms
    • Validation / Expense Reimbursement Sheet

“There must be a national commitment for Spain to remain at the forefront of clinical research”.

Increased international competitiveness and digitalisation will require more investment in infrastructure and resources to ensure that our country remains at the forefront of biomedical R&D

Source: farmaindustria.es

Today, a quality healthcare system is inconceivable without solid research activity, and it is the foundation on which a modern society must be built. This is because clinical research generates a virtuous circle that allows healthcare professionals to participate in the latest advances in science, in cooperation with colleagues from other countries, and to apply them to their healthcare work, which contributes to increasing the quality of healthcare provision; it opens up new opportunities for patients, especially relevant in serious cases that do not respond to the available therapeutic arsenal; it attracts funding from the sponsoring pharmaceutical companies to the participating hospitals, both public and private, and provides savings to healthcare systems.

Spain has understood the value of biomedical research in recent times and, as a result of years of work and public-private collaboration, together with the commitment of healthcare professionals and patients, it has become an international benchmark in this field, being for many pharmaceutical companies the second country, behind only the United States, in launching clinical trials.

This was recalled by the associate director of Clinical and Translational Research at Farmaindustria, Amelia Martín Uranga, last Wednesday at the second edition of the Hiris Healthcare Gala, where the conclusions of a survey of healthcare professionals were presented, revealing that they consider research to be essential for their professional updating and development and for improving the quality of care, but that, as negative aspects, they highlight the lack of time and resources.

In this sense, Martín Uranga stressed the need to promote the training of healthcare centres (primary care and hospital) to carry out clinical trials, especially those that carry out little or only sporadic research, providing them with infrastructure and personnel specialised in the management and execution of clinical trials. “Today, most clinical research is concentrated in two communities, Madrid and Catalonia, and it is time to work on the decentralisation of clinical trials, because it will benefit professionals and the health system, but above all, patients,” he said.

Coordination with regional health councils and services

This training, he said, must be carried out in close coordination with the regional health departments and health services of the autonomous communities, with managers committed to and involved in facilitating an ecosystem that favours clinical research. And not only that. Martín Uranga called for a “national commitment” to ensure that Spain remains at the forefront of biomedical research. “The increase in international competitiveness and digitalisation will require more investment in infrastructures and resources to ensure that our country remains at the forefront of biomedical R&D,” he said.

“The public-private collaboration model is a success story, as demonstrated by the coronavirus pandemic, so its strengthening and promotion should be considered as major challenges for the future of our healthcare system,” she added.

Finally, the Farmaindustria spokeswoman recalled that, in addition to Spain’s outstanding position in clinical research, we also have a high level of basic research; however, “there is a deficit of knowledge transfer between the two. In this area, the tractor effect that large pharmaceutical companies can have on emerging companies and public research centres is fundamental. We need to overcome obstacles and create stimuli that allow us to carry out an adequate transfer of technology and knowledge from the public to the private sector”.

Related entries

2 October, 2023

Decentralisation of trials, networking and digitisation, proposals to improve patient participation in clinical research


Leer más
26 September, 2023

More than 120 molecules in Alzheimer’s research, the great hope for patients, families and society


Leer más
19 September, 2023

The pharmaceutical industry’s plan to expand clinical trials in primary care


Leer más

Recent Posts

  • Decentralisation of trials, networking and digitisation, proposals to improve patient participation in clinical research
  • More than 120 molecules in Alzheimer’s research, the great hope for patients, families and society
  • The pharmaceutical industry’s plan to expand clinical trials in primary care
  • Health commitment to the pharmaceutical industry’s Strategic Plan to avoid losing 8,000 million euros
  • Improving patient access to innovative medicines and boosting R&D and manufacturing in Spain are the main priorities of the pharmaceutical industry

Contacta con nosotros


Tfno: +34 955.77.67.67
Fax: +34 955.77.65.56
info@distefar.net


Distefar del Sur
Sede Central

Distefar del Sur S.L.
Av. Umbrete, 58,
41110 Bollullos de la Mitación, Sevilla

Sede Madrid

Calle de Zurbano, 45, 28010 Madrid

CENTRAL

Pol. PIBO. Avda. de Gines, 14
+34 955 776 767 /+34 692 454 913
41110 Bollullos de la Mitación (Sevilla)

DELEGACIÓN MADRID

+34 674 575 115
28010 Madrid

Enlaces de interés

  • Aviso Legal
  • Política de privacidad
  • Política de cookies
  • Contacto

© 2023 Distefar del Sur SL. Todos los derechos reservados. agencianodo.com

  • No translations available for this page
  • Contact
  • Private Zone
  • English

    [recaptcha]

    In accordance with the provisions of Regulation (EU) 2016/679 and Organic Law 3/2018 regarding Data Protection, we inform you that the data you provide in this form will be incorporated into a file owned by DISTEFAR DEL SUR, SL domiciled in the C / Umbrete 58, (Pol. Ind. Pibo), 41110 of Bollullos de la Mitación (Seville), in order to manage your request.

    In this regard, and if you wish to exercise your rights of access, rectification, cancellation, opposition, portability and limitation, please send a written communication to DISTEFAR DEL SUR, SL, to the address indicated above or to info@distefar.com, attaching copy of your National Identity Document or equivalent identification document.

    Basic information about Data Protection

     Epigraph

    Basic information Data Protection

    Responsable

    DISTEFAR DEL SUR, S.L.

    Purpose

    Process your inquiry / request
    Detailed information on Data Protection

    Legitimation

    Consent
    Detailed information on Data Protection

    Recipients

    It is not expected to carry out data communications to third parties, except legal obligation
    Transfers of data to third countries outside the European Union will not be carried out
    Detailed information on Data Protection

    Rights

    You have the right of access, rectification, deletion, portability of your data, as well as limitation or opposition to your treatment, as detailed in Detailed information on Data Protection

    Additional Information

    You can consult the additional and detailed information on data protection by clicking here Detailed information on Data Protection

    All the data requested / The fields marked with * in the form are mandatory, if not filled in DISTEFAR DEL SUR, S.L. will not be able to meet your request.